Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

February 01, 1993; Volume 43,Issue 2
  • You have access
    Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.
    I Aramori, H Nirei, M Shoubo, K Sogabe, K Nakamura, H Kojo, Y Notsu, T Ono and S Nakanishi
    Molecular Pharmacology February 1993, 43 (2) 127-131;
  • You have access
    Regulation of basic fibroblast growth factor and nerve growth factor mRNA by beta-adrenergic receptor activation and adrenal steroids in rat central nervous system.
    P Follesa and I Mocchetti
    Molecular Pharmacology February 1993, 43 (2) 132-138;
  • You have access
    Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action.
    F F Moebius, G G Burrows, J Striessnig and H Glossmann
    Molecular Pharmacology February 1993, 43 (2) 139-148;
  • You have access
    Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.
    R P Yasuda, W Ciesla, L R Flores, S J Wall, M Li, S A Satkus, J S Weisstein, B V Spagnola and B B Wolfe
    Molecular Pharmacology February 1993, 43 (2) 149-157;
  • You have access
    Ethanol differentially regulates guanine nucleotide-binding protein alpha subunit expression in NG108-15 cells independently of extracellular adenosine.
    R J Williams, M A Veale, P Horne and E Kelly
    Molecular Pharmacology February 1993, 43 (2) 158-166;
  • You have access
    Solubilization and characterization of a guanine nucleotide-sensitive form of the calcitonin gene-related peptide receptor.
    T K Chatterjee, J A Moy, J J Cai, H C Lee and R A Fisher
    Molecular Pharmacology February 1993, 43 (2) 167-175;
  • You have access
    Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
    Y Amano, S W Lee and A C Allison
    Molecular Pharmacology February 1993, 43 (2) 176-182;
  • You have access
    Purification from liver microsomes from untreated cynomolgus monkeys of cytochrome P450 closely related to human cytochrome P450 2B6.
    S Ohmori, C Shirakawa, K Motohashi, H Yoshida, H Abe, T Nakamura, T Horie, H Kitagawa, K Asaoka and T Rikihisa
    Molecular Pharmacology February 1993, 43 (2) 183-190;
  • You have access
    Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2.
    U Fuhr, G Strobl, F Manaut, E M Anders, F Sörgel, E Lopez-de-Brinas, D T Chu, A G Pernet, G Mahr and F Sanz
    Molecular Pharmacology February 1993, 43 (2) 191-199;
  • You have access
    alpha-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation.
    M Santostefano, M Merchant, L Arellano, V Morrison, M S Denison and S Safe
    Molecular Pharmacology February 1993, 43 (2) 200-206;
  • You have access
    Topoisomerase II activity involved in cleaving DNA into topological domains is altered in a multiple drug-resistant Chinese hamster ovary cell line.
    D M Sullivan, L A Eskildsen, K R Groom, C D Webb, M D Latham, A W Martin, S R Wellhausen, P E Kroeger and T C Rowe
    Molecular Pharmacology February 1993, 43 (2) 207-216;
  • You have access
    Identification of the benzomorphan opiate binding site on the catalytic subunit of acetylcholinesterase.
    B A Coleman and R E Oswald
    Molecular Pharmacology February 1993, 43 (2) 217-225;
  • You have access
    Rat small intestinal cytochromes P450 probed by warfarin metabolism.
    M J Fasco, J B Silkworth, D A Dunbar and L S Kaminsky
    Molecular Pharmacology February 1993, 43 (2) 226-233;
  • You have access
    Correlation of human cytochrome P4502C substrate specificities with primary structure: warfarin as a probe.
    L S Kaminsky, S M de Morais, M B Faletto, D A Dunbar and J A Goldstein
    Molecular Pharmacology February 1993, 43 (2) 234-239;
  • You have access
    Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes.
    K A Wafford, P J Whiting and J A Kemp
    Molecular Pharmacology February 1993, 43 (2) 240-244;
  • You have access
    Beta gamma subunits of guanine nucleotide-binding proteins and regulation of spontaneous receptor activity: thermodynamic model for the interaction between receptors and guanine nucleotide-binding protein subunits.
    H O Onaran, T Costa and D Rodbard
    Molecular Pharmacology February 1993, 43 (2) 245-256;
  • You have access
    Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning.
    M J Burkitt, M B Kadiiska, P M Hanna, S J Jordan and R P Mason
    Molecular Pharmacology February 1993, 43 (2) 257-263;
  • You have access
    Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding.
    S C Wall, R B Innis and G Rudnick
    Molecular Pharmacology February 1993, 43 (2) 264-270;
  • You have access
    Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters.
    G Rudnick and S C Wall
    Molecular Pharmacology February 1993, 43 (2) 271-276;
  • You have access
    Functional expression of adenosine A2b receptor in Xenopus oocytes.
    J L Yakel, R A Warren, S M Reppert and R A North
    Molecular Pharmacology February 1993, 43 (2) 277-280;
  • You have access
    D1A dopamine receptor stimulation inhibits Na+/K(+)-ATPase activity through protein kinase A.
    A Horiuchi, K Takeyasu, M M Mouradian, P A Jose and R A Felder
    Molecular Pharmacology February 1993, 43 (2) 281-285;
  • You have access
    Regulation of phosphatidylinositol 4-kinase activity in rat pancreatic acini.
    B R Conway, M Withiam-Leitch and R P Rubin
    Molecular Pharmacology February 1993, 43 (2) 286-292;
  • You have access
    Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67.
    M Lakitsch, H G Knaus, G Topar, C Romanin, R Boer, D Flockerzi, J Striessnig, H Schindler, H D Hoeltje and H Glossmann
    Molecular Pharmacology February 1993, 43 (2) 293-301;
  • You have access
    Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
    P C Ring, P M Seldon, P J Barnes and M A Giembycz
    Molecular Pharmacology February 1993, 43 (2) 302-312;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 43, Issue 2
1 Feb 1993
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics